Harpreet Singh Bajaj is a community Endocrinologist in Brampton and a Research Associate at Leadership Sinai Centre for Diabetes at Mount Sinai Hospital in Toronto.
Dr. Bajaj is an adjunct lecturer at McMaster University and University of Western Ontario. He is the founding chairman of STOP Diabetes Foundation, a registered charitable foundation, working to reduce the burden of diabetes in Peel region of Ontario. He serves as the co-chair of the Communications and Marketing portfolio within Diabetes Canada’s professional section national executive as well as a national consultant editor for Canadian Journal for Diabetes.
Dr. Bajaj has pioneered “real-life” practical approaches to research in diabetes, obesity and cardiovascular risk assessment. He has co-authored publications in key medical journals such as Diabetes Care, Diabetes Technology and Therapeutics, Nature Reviews, Nature Publishing Group’s Obesity journal, Journal of American Medical Association (JAMA) and Canadian Journal of Diabetes (CJD). He has an interest in ethnicity-based research with a focus on diabetes and cardiometabolic diseases in South Asian community. He has developed and presented numerous lectures to a variety of audiences (specialists, family physicians, diabetes educators, pharmacists, public) on various topics related to diabetes. He hosts a weekly TV show called “Your Health” on South-Asian Canadian Channel Y to educate viewers about health and lifestyle.
Dr. Bajaj’s medical education was at Maulana Azad Medical College in New Delhi, India. He completed his Endocrinology fellowship at the Cleveland Clinic in Ohio, USA and a Masters of Public Health (Epidemiology) at State University of New York in Albany, USA. He has been living in Canada, with his family and parents since 2009.
By way of his work in the clinic setting, public awareness efforts, CME lectures to specialist and family practice colleagues as well as research activities, Dr. Bajaj is committed to improving the provision of diabetes related health care in Canada.
Industry Expertise (4)
Health and Wellness
Health Care - Services
Areas of Expertise (5)
Endocrinology and Metabolism
State University of New York at Albany: Master of Public Health, MPH, Epidemiology 2004
Maulana Azad Medical College: Bachelor of Medicine, Bachelor of Surgery (MBBS), Medicine 2000
- Clinical Endocrinologist LMC Diabetes & Endocrinology
- Research Associate Leadership Sinai Centre for Diabetes Mount Sinai Hospital Toronto
- Founding Chairman "STOP Diabetes" Foundation Inc.
Media Appearances (4)
Celebrating the Festival of Lights And making good health part of the fun
Toronto Sun online
South Asians in particular are prone to these medical problems, adds Dr. Harpreet Bajaj, a Brampton, Ont.,-based endocrinologist and councillor with the Canadian Diabetes Assoc., as well as founder of the STOP Diabetes Foundation. "As many as 50% of people with diabetes may show signs of kidney damage, and patients of South Asian ethnicity experience a more rapid progression of chronic kidney disease," notes Bajaj, adding people can still enjoy the festival - just by making small lifestyle changes: "It can be as easy as just saying no to sweets and practising portion control. South Asians often feel that serving more food represents more love for friends and family. Say no to seconds, choose smaller portions and don't drink your calories is a good start."
105-year-old marathoner coming to Peel Region to share healthy living advice
CBC News online
Endocrinologist Dr. Harpreet Singh Bajaj, founder of the STOP Diabetes Foundation, invited Singh to speak at this weekend's event, which is aimed at a community with a high rate of diabetes. "He runs for health and he wants to inspire people to take up running for health," Bajaj said Friday in an interview on CBC Radio's Metro Morning. "He's inspired me to start running. Last year I completed my first marathon."
Campaigns in Peel to curb the tide of diabetes will educate and empower
Mississauga News online
Peel-based advocacy group wants to stem the rising tide of diabetes in the region through awareness and education among the region’s South Asian population. To that end, Stop Diabetes Foundation, a non-profit founded by Brampton Endocrinologist Dr. Harpreet Bajaj, hosted an information session for the community, Sunday, June 21 at the Mississauga Convention Day at 75 Derry Rd. W.
Local woman modifies Diwali recipes to prevent diabetes
CTV Toronto tv
Diwali recipes modified for those living with diabetes.
Event Appearances (1)
Let's Out Run Diabetes Bramton
2016 Background: Basal insulin titration in the real world is often unsuccessful. LTHome, a web tool, applies a rules engine-based algorithm providing insulin titration advice directly to the patient. Methods: This pilot, randomized trial evaluates basal insulin glargine titration by LTHome compared to enhanced usual therapy ([EUT]—diabetes education program) over 12 weeks. Important inclusion criteria: 18–75 years, type 2 diabetes, computer literacy, and HbA1c >7.0%. Trial protocol was approved by ethics board...
2016 Breastfeeding ≥12 months is recommended for optimal infant nutrition but may hold maternal benefits, as well. Indeed, lactation has been associated with lower long-term risk of diabetes in the mother but the mechanism by which it imparts sustained post-weaning effects on glucose tolerance remains unclear. In this context, we postulated that lactation potentially could induce post-weaning beneficial effects on glucose tolerance by modifying the natural history of insulin sensitivity and/or pancreatic beta-cell function over time...
2016 OBJECTIVE There is a dearth of published literature comparing glucose variability (GV) between different insulin regimens in type 2 diabetes. This cohort study compares GV using continuous glucose monitoring (CGM) in patients with well-controlled type 2 diabetes using four common insulin regimens: basal insulin + oral drugs (BO), basal insulin + glucagon-like peptide 1 receptor agonist (GLP-1 RA) (BGLP), premixed insulin (PM), and basal-bolus insulin (BB). RESEARCH DESIGN AND METHODS Consecutive patients from three endocrinology clinics who met study criteria—type 2 diabetes, age 18 to 80 years, BMI ≤ 45 kg/m2, stable insulin regimen for a minimum of 6 months, and stable A1C value ≤7.5% (58 mmol/mol) before study enrollment—underwent 6-day masked CGM. Hypoglycemia was defined as a sensor glucose concentration
In the Steno-2 trial, 160 individuals with type 2 diabetes mellitus, mostly in their 50s, were randomly assigned to multifactorial interventions or conventional care. Whereas microvascular and macrovascular complications were reduced during the 7.8 years of the trial period with intensive therapy, the observational follow-up data at 13.3 years and, now, 21 years demonstrate a benefit on mortality.
Race- and sex-stratified sample sizes and unadjusted anthropometric characteristics are shown in Table 1. Briefly, Asian Indian men and women had substantially lower height, weight, body mass index (BMI), WC, hip circumference (HC), and body surface area relative to all US ethnic groups (all sex-specific P values